← FDA Drug Approvals (Drugs@FDA)

GLATIRAMER ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2017-10-03

Drug application

FDA Application #

ANDA206936

Application type

Abbreviated New Drug Application (Generic)

Brand name

GLATIRAMER ACETATE

Generic name

GLATIRAMER

Active ingredients

GLATIRAMER ACETATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

MYLAN

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2017-10-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown